pubmed-article:2127036 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2127036 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:2127036 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:2127036 | lifeskim:mentions | umls-concept:C0596620 | lld:lifeskim |
pubmed-article:2127036 | lifeskim:mentions | umls-concept:C1268900 | lld:lifeskim |
pubmed-article:2127036 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:2127036 | pubmed:dateCreated | 1991-4-3 | lld:pubmed |
pubmed-article:2127036 | pubmed:abstractText | We report a case of an insulin-dependent diabetic female who received leuprolide acetate and Depo-Lurpon for the treatment of endometriosis. Their use was associated with hyperglycemia and a deterioration in glucose control that necessitated changes in insulin dosage. | lld:pubmed |
pubmed-article:2127036 | pubmed:language | eng | lld:pubmed |
pubmed-article:2127036 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2127036 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2127036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2127036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2127036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2127036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2127036 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2127036 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2127036 | pubmed:issn | 0378-7346 | lld:pubmed |
pubmed-article:2127036 | pubmed:author | pubmed-author:CoddingtonC... | lld:pubmed |
pubmed-article:2127036 | pubmed:author | pubmed-author:JonesG SGS | lld:pubmed |
pubmed-article:2127036 | pubmed:author | pubmed-author:HarrisonH CHC | lld:pubmed |
pubmed-article:2127036 | pubmed:author | pubmed-author:BrzyskiR GRG | lld:pubmed |
pubmed-article:2127036 | pubmed:author | pubmed-author:HassiakosD... | lld:pubmed |
pubmed-article:2127036 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2127036 | pubmed:volume | 30 | lld:pubmed |
pubmed-article:2127036 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2127036 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2127036 | pubmed:pagination | 246-8 | lld:pubmed |
pubmed-article:2127036 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:meshHeading | pubmed-meshheading:2127036-... | lld:pubmed |
pubmed-article:2127036 | pubmed:year | 1990 | lld:pubmed |
pubmed-article:2127036 | pubmed:articleTitle | Effect of a gonadotropin-releasing hormone analogue on the glucose metabolism in a diabetic patient. | lld:pubmed |
pubmed-article:2127036 | pubmed:affiliation | Department of Obstetrics and Gynecology, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk. | lld:pubmed |
pubmed-article:2127036 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2127036 | pubmed:publicationType | Case Reports | lld:pubmed |